RIO RANCHO, N.M.–(BUSINESS WIRE)–Nature’s Toolbox, Inc. (NTx), a life sciences company building next generation platforms to manufacture RNA and protein, announced today that it has raised $47.5M in Series B financing. Led by RA Capital Management, the investment will fuel the advancement of the company’s biomanufacturing platforms, NTxscribe® and NTxpress®. Acceleration of these technology foundations will enable distribution of manufacturing capabilities globally, ultimately providing solutions to prepare for future pandemic events, personalized medicine therapy, and increased access to critical vaccines and medicines. READ MORE
—